Skip to main content
. 2021 Apr 9;143(20):1962–1972. doi: 10.1161/CIRCULATIONAHA.121.053659

Figure 5.

Figure 5.

Effect of dapagliflozin on cardiovascular death or HF hospitalization using a time-to-first event Cox model, recurrent HF hospitalizations or cardiovascular death using the LWYY method and joint frailty model. CV indicates cardiovascular; HF, heart failure; and LWYY, Lin-Wei-Yang-Ying.